CENTENNIAL, Colo., March 8, 2023 /PRNewswire/ -- AlloSource®, one of the largest allograft providers creating innovative cellular and tissue products to help surgeons heal their patients, today ...
Organogenesis Holdings Inc. (NASDAQ: ORGO) shared topline data on Thursday from the second Phase 3 randomized controlled trial (RCT) of ReNu, a cryopreserved amniotic suspension allograft (ASA) for ...
FRESNO, Calif. (KFSN) -- More than one-third of all Americans report being affected by knee pain. Knee replacement surgery can offer relief, but the implants only last between 12 and 15 years.